These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7584882)

  • 41. Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. Finnprostate Group.
    Mikkola AK; Ruutu ML; Aro JL; Rannikko SA; Salo JO
    Br J Urol; 1998 Jul; 82(1):63-8. PubMed ID: 9698663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost comparison of parenteral estrogen and conventional hormonal treatment in patients with prostatic cancer.
    Henriksson P; Stege R
    Int J Technol Assess Health Care; 1991; 7(2):220-5. PubMed ID: 1907600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer.
    Henriksson P; Edhag O; Eriksson A; Johansson SE
    Br J Urol; 1989 Feb; 63(2):186-90. PubMed ID: 2649197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate.
    Henriksson P; Eriksson A; Stege R; Collste L; Pousette A; von Schoultz B; Carlström K
    Prostate; 1988; 13(3):257-61. PubMed ID: 3211807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma.
    Agardh CD; Nilsson-Ehle P; Lundgren R; Gustafson A
    J Urol; 1984 Nov; 132(5):1021-4. PubMed ID: 6492270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial therapy of advanced prostate cancer.
    Ismail M; Gomella LG
    Compr Ther; 1997 Oct; 23(10):649-55. PubMed ID: 9327180
    [No Abstract]   [Full Text] [Related]  

  • 48. High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.
    Aro JL; Haapiainen RK; Rannikko SA; Alfthan OS
    Br J Urol; 1989 May; 63(5):512-4. PubMed ID: 2659136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma.
    Henriksson P; Angelin B; Berglund L
    J Clin Invest; 1992 Apr; 89(4):1166-71. PubMed ID: 1532586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deleterious effects of low-dose oestrogen therapy on coronary status in patients with prostatic cancer.
    Henriksson P; Linde B; Edhag O
    Eur Heart J; 1987 Jul; 8(7):779-84. PubMed ID: 3653128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma lipoproteins during anti-androgen treatment by estrogens or orchidectomy in men with prostatic carcinoma.
    Wallentin L; Varenhorst E
    Horm Metab Res; 1981 May; 13(5):293-7. PubMed ID: 7262828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of combined therapy of prostate cancer; orchiectomy with estrogens].
    HOLDER E
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1953; 275(3-4):178-90. PubMed ID: 13098150
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost-effectiveness comparison of estrogen therapy and orchidectomy in patients with prostatic cancer.
    Henriksson P; Edhag O
    Int J Technol Assess Health Care; 1987; 3(4):523-9. PubMed ID: 10312366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Studies of clinical effects of ethinyl estradiol (a natural estrogen) on prostatic carcinoma (author's transl)].
    Kitajima N; Hosaka M; Fujii H; Mishimura R; Takai S
    Horumon To Rinsho; 1981 Feb; 29(2):223-8. PubMed ID: 7261442
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of orchidectomy performed after cessation of estrogen therapy on serum testosterone concentrations in patients with prostatic carcinoma.
    Tomić R; Damber JE
    Urol Int; 1987; 42(6):441-4. PubMed ID: 3129850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer.
    Henriksson P; Blombäck M; Bratt G; Edhag O; Eriksson A; Vesterqvist O
    Med Oncol Tumor Pharmacother; 1989; 6(3):219-25. PubMed ID: 2515399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward personalizing the use of androgen deprivation therapy to maximize benefit and minimize harm.
    Nguyen PL; D'Amico AV
    Eur Urol; 2015 Sep; 68(3):397-8. PubMed ID: 25542627
    [No Abstract]   [Full Text] [Related]  

  • 59. Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens.
    Damber JE; Bergman B; Södergård R; Tomić R
    J Endocrinol Invest; 1983 Apr; 6(2):91-4. PubMed ID: 6683289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.
    Genant HK; Lucas J; Weiss S; Akin M; Emkey R; McNaney-Flint H; Downs R; Mortola J; Watts N; Yang HM; Banav N; Brennan JJ; Nolan JC
    Arch Intern Med; 1997 Dec 8-22; 157(22):2609-15. PubMed ID: 9531230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.